CONDUENT INC (CNDT)

US2067871036 - Common Stock

3.06  +0.07 (+2.34%)

After market: 3.06 0 (0%)

Fundamental Rating

2

Overall CNDT gets a fundamental rating of 2 out of 10. We evaluated CNDT against 86 industry peers in the IT Services industry. CNDT has a bad profitability rating. Also its financial health evaluation is rather negative. CNDT does not seem to be growing, but still is valued expensively.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

CNDT had negative earnings in the past year.
In the past year CNDT had a positive cash flow from operations.
CNDT had negative earnings in each of the past 5 years.
Each year in the past 5 years CNDT had a positive operating cash flow.

1.2 Ratios

CNDT has a worse Return On Assets (-9.68%) than 67.86% of its industry peers.
With a Return On Equity value of -39.69%, CNDT is not doing good in the industry: 67.86% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 3.72%, CNDT is in line with its industry, outperforming 55.95% of the companies in the same industry.
CNDT had an Average Return On Invested Capital over the past 3 years of 3.43%. This is significantly below the industry average of 12.84%.
The 3 year average ROIC (3.43%) for CNDT is below the current ROIC(3.72%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -9.68%
ROE -39.69%
ROIC 3.72%
ROA(3y)-5.33%
ROA(5y)-12.41%
ROE(3y)-20.27%
ROE(5y)-41.04%
ROIC(3y)3.43%
ROIC(5y)2.36%

1.3 Margins

CNDT has a Operating Margin (2.90%) which is comparable to the rest of the industry.
CNDT's Operating Margin has declined in the last couple of years.
CNDT has a worse Gross Margin (22.41%) than 72.62% of its industry peers.
CNDT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.9%
PM (TTM) N/A
GM 22.41%
OM growth 3Y59.09%
OM growth 5Y-5.71%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.75%
GM growth 5Y-0.04%

More info and screens

2

2. Health

2.1 Basic Checks

CNDT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CNDT has less shares outstanding than it did 1 year ago.
CNDT has more shares outstanding than it did 5 years ago.
CNDT has a worse debt/assets ratio than last year.

2.2 Solvency

CNDT has an Altman-Z score of 0.48. This is a bad value and indicates that CNDT is not financially healthy and even has some risk of bankruptcy.
CNDT has a Altman-Z score of 0.48. This is in the lower half of the industry: CNDT underperforms 65.48% of its industry peers.
CNDT has a Debt/Equity ratio of 1.62. This is a high value indicating a heavy dependency on external financing.
CNDT has a Debt to Equity ratio of 1.62. This is in the lower half of the industry: CNDT underperforms 70.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.62
Debt/FCF N/A
Altman-Z 0.48
ROIC/WACC0.38
WACC9.69%

2.3 Liquidity

A Current Ratio of 1.91 indicates that CNDT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.91, CNDT is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
CNDT has a Quick Ratio of 1.91. This is a normal value and indicates that CNDT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.91, CNDT is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.91

More info and screens

1

3. Growth

3.1 Past

CNDT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -121.74%.
The Revenue has decreased by -3.53% in the past year.
The Revenue has been decreasing by -7.15% on average over the past years.
EPS 1Y (TTM)-121.74%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q200%
Revenue 1Y (TTM)-3.53%
Revenue growth 3Y-3.66%
Revenue growth 5Y-7.15%
Revenue growth Q2Q-3.35%

3.2 Future

The Earnings Per Share is expected to decrease by -86.23% on average over the next years. This is quite bad
CNDT is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.02% yearly.
EPS Next Y-104%
EPS Next 2Y-86.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.91%
Revenue Next 2Y-3.02%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CNDT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CNDT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNDT indicates a rather cheap valuation: CNDT is cheaper than 91.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.78

4.3 Compensation for Growth

A cheap valuation may be justified as CNDT's earnings are expected to decrease with -86.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-86.23%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CNDT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONDUENT INC

NASDAQ:CNDT (4/26/2024, 7:00:00 PM)

After market: 3.06 0 (0%)

3.06

+0.07 (+2.34%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap638.44M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.68%
ROE -39.69%
ROCE
ROIC
ROICexc
ROICexgc
OM 2.9%
PM (TTM) N/A
GM 22.41%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 1.62
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.91
Quick Ratio 1.91
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-121.74%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-104%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-3.53%
Revenue growth 3Y-3.66%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y